Final results from the prospective phase III WSG-ARA trial: impact of adjuvant darbepoetin alfa on event-free survival in early breast cancer
Autor: | Nitz, U. *, Gluz, O., Zuna, I., Oberhoff, C., Reimer, T., Schumacher, C., Hackmann, J., Warm, M., Uleer, C., Runde, V., Dünnebacke, J., Belzl, N., Augustin, D., Kates, R.E., Harbeck, N. |
---|---|
Zdroj: | In Annals of Oncology January 2014 25(1):75-80 |
Databáze: | ScienceDirect |
Externí odkaz: |